ResearcherRenmin Hospital of Wuhan UniversityNo recent work listed
Weiguo Dong
Matched on ORCID iD 0000-0002-4228-6508; OpenAlex author ID A5057948360.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Collaborators
- 3
2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 3
- Calpain2 Upregulation Regulates EMT-Mediated Pancreatic Cancer Metastasis via the Wnt/β-Catenin Signaling Pathway. Last author DOI 10.3389/fmed.2022.783592↗
- EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway. Co-author DOI 10.3892/etm.2015.2684↗
- EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2. Co-author DOI 10.3892/etm.2014.1831↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Xiulan Peng · 3 shared papers, 2014–2022
- Paper Calpain2 Upregulation Regulates EMT-Mediated Pancreatic Cancer Metastasis via the Wnt/β-Catenin Signaling Pathway. DOI 10.3389/fmed.2022.783592↗
- Paper EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway. DOI 10.3892/etm.2015.2684↗
- Paper EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2. DOI 10.3892/etm.2014.1831↗
- Mengyao Ji · 2 shared papers, 2014–2015
- Lei Yuan · 1 shared paper, 2015
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.